References: Assessment of bleeding risk for anticoagulant therapy

  • Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016;149(2):315-52. https://www.ncbi.nlm.nih.gov/pubmed/26867832
  • Lip GY. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur Heart J 2013;34(14):1041-9. https://www.ncbi.nlm.nih.gov/pubmed/23257951
  • Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ, et al. Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 2021;160(6):2247-59. https://www.ncbi.nlm.nih.gov/pubmed/34352279